Effect of aspirin on exercise-induced angina.
Suspecting that platelet thromboemboli could play a role in the pathogenesis of myocardial ischemia, we did a random-order, double-blind, crossover study of the effect of the platelet aggregation inhibitor, aspirin, on treadmill exercise-induced angina in 13 men with coronary artery disease. Although collagen-induced platelet aggregation and the second phase of adenosine diphosphate (ADP)-induced platelet aggregation were significantly decreased and the rate of disaggregation of ADP-induced platelet aggregates was significantly increased after 650 mg aspirin in buffered solution, there was no delay in onset of exercise-induced angina, change in heart rate-blood pressure product at onset of angina, or change in S-T segment depression at onset of angina. Regardless of whether the patients had received placebo or aspirin on the preceding day, treadmill exercise until angina was followed by no changes in platelet aggregation or disaggregation, platelet count in blood or platelet-rich plasma, or of the plasma concentration of nonesterified fatty acids.
D000328:Adult; D000787:Angina Pectoris / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use*; D001772:Blood Cell Count; D001792:Blood Platelets / Q000187:drug effects; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D005082:Physical Exertion; D010974:Platelet Aggregation / Q000187:drug effects
D005230:Fatty Acids, Nonesterified; D001241:Aspirin